Eli Lilly, known for its blockbuster weight-loss and anti-diabetes drugs, is now focusing on neurosciences, with significant ...

Discover how India is addressing cancer drug affordability with a new pricing strategy that aims to lower costs for patients ...

Despite beating quarterly sales and profit expectations, GSK's stock fell due to concerns over its drug pipeline and weak ...

Eli Lilly has announced that its experimental obesity drug, retatrutide, has outperformed Novo's Ozempic in a Phase 3 trial, ...

The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...

Despite a 30% cap on trade margins for non-scheduled cancer drugs, prices for branded cancer medications remain unchanged, ...

Despite a $2.2 billion setback due to failed drug trials, Novartis raises its profit forecast for the year, highlighting ...

The CDSCO has raised a public alert regarding a counterfeit batch of the liver medication Defitelio, prompting patients to ...

Hengrui Pharmaceuticals, China's leading drugmaker, reported an impressive 88.9% increase in net profit for Q3 2026, driven ...

The FDA has cautioned Amgen about a promotional video for Vectibix, its colorectal cancer drug, which allegedly ...

Cipla's bispecific ADC rolditamig deruxtecan demonstrates a remarkable 71% reduction in disease progression for late-stage ...

India's drug regulator DCGI cancels the import registration of FatX, a cosmetic product marketed with unauthorized ...